170 related articles for article (PubMed ID: 25252705)
41. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
42. Access to hepatitis C treatment for people who inject drugs in low and middle income settings: Evidence from 5 countries in Eastern Europe and Asia.
Luhmann N; Champagnat J; Golovin S; Maistat L; Agustian E; Inaridze I; Myint WM; Butsashvili M; Bouscaillou J
Int J Drug Policy; 2015 Nov; 26(11):1081-7. PubMed ID: 26342273
[TBL] [Abstract][Full Text] [Related]
43. HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming.
Baluku M; Wamala T; Muhangi D
Harm Reduct J; 2019 Sep; 16(1):56. PubMed ID: 31481086
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
45. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
[TBL] [Abstract][Full Text] [Related]
46. Training the healthcare workforce to support task-shifting and viral hepatitis elimination: a global review of English language online trainings and in-person workshops for management of hepatitis B and C infection.
Corcorran MA; Scott JD; Naveira M; Easterbrook P
BMC Health Serv Res; 2023 Aug; 23(1):849. PubMed ID: 37568106
[TBL] [Abstract][Full Text] [Related]
47. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
Stone KA
Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
[TBL] [Abstract][Full Text] [Related]
48. Innovative community-based educational face-to-face intervention to reduce HIV, hepatitis C virus and other blood-borne infectious risks in difficult-to-reach people who inject drugs: results from the ANRS-AERLI intervention study.
Roux P; Le Gall JM; Debrus M; Protopopescu C; Ndiaye K; Demoulin B; Lions C; Haas A; Mora M; Spire B; Suzan-Monti M; Carrieri MP
Addiction; 2016 Jan; 111(1):94-106. PubMed ID: 26234629
[TBL] [Abstract][Full Text] [Related]
49. Deceased organ donor screening for HIV, hepatitis B, and hepatitis C viruses: a survey of organ procurement organization practices.
Theodoropoulos N; Jaramillo A; Ladner DP; Ison MG
Am J Transplant; 2013 Aug; 13(8):2186-90. PubMed ID: 23711196
[TBL] [Abstract][Full Text] [Related]
50. Can hepatitis C be eradicated in the United States?
Edlin BR; Winkelstein ER
Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of and risk factors for HBV and HCV among incarcerated people who inject drugs in Iran: A cross sectional study.
Moradi G; Mohamadi P; Zareie B; Rasouli MA; Gouya MM; Jafari S
BMC Infect Dis; 2020 Oct; 20(1):806. PubMed ID: 33129259
[TBL] [Abstract][Full Text] [Related]
52. [European and North American regulations on employing HBV-, HCV- and HIV-infected persons in health care].
Hofmann F; Hasselhorn HM
Chirurg; 2000 Apr; 71(4):396-403. PubMed ID: 10840607
[TBL] [Abstract][Full Text] [Related]
53. Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugs.
Palmateer NE; Goldberg DJ; Munro A; Taylor A; Yeung A; Wallace LA; Mitchell A; Shepherd SJ; Gunson RN; Aitken C; Hutchinson SJ
Addiction; 2018 Jan; 113(1):80-90. PubMed ID: 28710874
[TBL] [Abstract][Full Text] [Related]
54. Access to hepatitis C care for people who inject drugs and people in prisons.
Oru E; Verster A
Lancet Gastroenterol Hepatol; 2019 Sep; 4(9):662-663. PubMed ID: 31362917
[No Abstract] [Full Text] [Related]
55. Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings.
Horváth I; Mårdh O; Schwarz T
BMC Health Serv Res; 2023 Dec; 23(1):1352. PubMed ID: 38049823
[TBL] [Abstract][Full Text] [Related]
56. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
Arain A; Robaeys G
World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
[TBL] [Abstract][Full Text] [Related]
57. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
[TBL] [Abstract][Full Text] [Related]
58. A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.
Zimmermann R; Marcus U; Schäffer D; Leicht A; Wenz B; Nielsen S; Santos-Hövener C; Ross RS; Stambouli O; Ratsch BA; Bannert N; Bock CT; Kücherer C; Hamouda O
BMC Public Health; 2014 Aug; 14():845. PubMed ID: 25124485
[TBL] [Abstract][Full Text] [Related]
59. Moving towards hepatitis B elimination in Gulf Health Council states: From commitment to action.
Al Awaidy ST; Ezzikouri S
J Infect Public Health; 2020 Feb; 13(2):221-227. PubMed ID: 31445879
[TBL] [Abstract][Full Text] [Related]
60. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.
Hope VD; Eramova I; Capurro D; Donoghoe MC
Epidemiol Infect; 2014 Feb; 142(2):270-86. PubMed ID: 23714072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
